184781-26-8

Basic information

• Product Name: 3-{2-[(2S,3R,4R,5S)-5-Amino-3,4-bis-benzyloxy-2-(tert-butyl-dimethyl-silanyloxymethyl)-piperidin-1-yl]-ethyl}-indole-1-carboxylic acid tert-butyl ester
• CAS NO: 184781-26-8
• Molecular Weight: 700.006
• Mol File: 184781-26-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-{2-[(2S,3R,4R,5S)-5-Amino-3,4-bis-benzyloxy-2-(tert-butyl-dimethyl-silanyloxymethyl)-piperidin-1-yl]-ethyl}-indole-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-{2-[(2S,3R,4R,5S)-5-Amino-3,4-bis-benzyloxy-2-(tert-butyl-dimethyl-silanyloxymethyl)-piperidin-1-yl]-ethyl}-indole-1-carboxylic acid tert-butyl ester(184781-26-8)
• EPA Substance Registry System: 3-{2-[(2S,3R,4R,5S)-5-Amino-3,4-bis-benzyloxy-2-(tert-butyl-dimethyl-silanyloxymethyl)-piperidin-1-yl]-ethyl}-indole-1-carboxylic acid tert-butyl ester(184781-26-8)

Safety Data

• Hazardous Substances Data: 184781-26-8(Hazardous Substances Data)

Upstream product

• 182066-06-4 3-{2-[(2S,3R,4R,5R)-3,4-Bis-benzyloxy-2-(tert-butyl-dimethyl-silanyloxymethyl)-5-hydroxy-piperidin-1-yl]-ethyl}-indole-1-carboxylic acid tert-butyl ester 
• 182066-02-0 3-[2-((2S,3R,4R,5R)-3,4-Bis-benzyloxy-5-hydroxy-2-hydroxymethyl-piperidin-1-yl)-ethyl]-indole-1-carboxylic acid tert-butyl ester 
• 182066-01-9 3,4-di-O-benzyl-1,5-dideoxy-1,5-[2'-(1H-indol-3-yl)-ethyl]-imino-L-gulitol 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 61-54-1 tryptamine 
• 182066-12-2 3-{2-[(2S,3R,4R,5S)-5-Azido-3,4-bis-benzyloxy-2-(tert-butyl-dimethyl-silanyloxymethyl)-piperidin-1-yl]-ethyl}-indole-1-carboxylic acid tert-butyl ester 

Downstream Products

• 182066-25-7 3-{2-[(2S,3R,4R,5S)-3,4-Bis-benzyloxy-5-(6-tert-butoxycarbonylamino-hexylamino)-2-(tert-butyl-dimethyl-silanyloxymethyl)-piperidin-1-yl]-ethyl}-indole-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Design, synthesis and binding affinities of novel non-peptide mimics of somatostatin/Sandostatin

Based on molecular modelling studies of Sandostatin, sugar-based derivatives I-VI were prepared as potential non-peptide mimics of somatostatin/Sandostatin. These compounds displaced 3-[125I]-Tyr11-SRIF-14 from the somatostatin receptor on membranes of rat cerebral cortex with IC50 values between 10 and 15 μM.